Ads
related to: what is hepatitis b
Search results
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash
FierceBiotech· 4 hours agoBarinthus Biotherapeutics has used positive interim data from a pair of phase 2 trials for its ...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 6 days agoROCK HILL, S.C. - Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from...
Two Philadelphia-area biotech firms report progress on pursuit of a hepatitis B cure - Philadelphia...
The Business Journals· 7 days agoTwo local life sciences companies reported progress this week on their efforts to develop a cure for...
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 3 hours agoGSK AI and machine learning global head and senior vice-president Kim Branson stated: “In addition...
High-risk health workers can get routine Ebola vaccine, says Gavi
Reuters via Yahoo News· 1 hour agoA global stockpile of Ebola vaccines can be used to protect frontline health workers in high-risk...
GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M
FierceBiotech· 7 days agoAfter taking 11 months to get to know Elsie Biotechnologies' oligonucleotide platform, GSK is ready...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 6 days agoGSK chief scientific officer Tony Wood stated: “We have already made great strides in...
How Bad Is It to Borrow My Partner’s Toothbrush From Time to Time?
Self via Yahoo News· 19 hours agoMore specifically, borrowing any personal hygiene tool (like a razor or toothbrush) can potentially...
Barinthus Biotherapeutics plc (NASDAQ:BRNS) Short Interest Update
ETF DAILY NEWS· 5 hours agoBarinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 5,800 ...
Barinthus Biotherapeutics to slash about 25% of its workforce
Market Watch· 17 hours agoexpects to cut about 25% of its workforce in connection with a pipeline prioritization. The company said it will prioritize development of VTP-300 in chronic hepatitis < ...
Ad
related to: what is hepatitis b